Description
Turinabol (“Chlorodehydromethyltestosterone”) Overview:
Turinabol, also known as “Chlorodehydromethyltestosterone,” is a potent oral steroid derived from Methandienone. Structurally resembling Methandienone with the addition of a 4-chloro alteration, Turinabol exhibits milder estrogenic and androgenic properties compared to its counterpart. While its anabolic activity is slightly lower, it offers a more favorable balance of anabolic to androgenic effects, reducing the likelihood of androgenic side effects.
Contents:
Each tablet typically contains 10 mg of Turinabol, known chemically as 4-Chlordehydromethyltestosterone.
Side Effects:
While considered milder than other anabolic steroids, Turinabol still presents potential side effects. It does not cause estrogen-related issues like water retention or gynecomastia, but can be he
patotoxic and impact cardiovascular health. Additionally, it suppresses natural testosterone production, necessitating a testosterone base and post-cycle therapy.
Administration:
Clinical dosages of Turinabol range from 5 mg per day for women to 15-40 mg per day for athletes. Cycles typically last 6-8 weeks to minimize hepatotoxicity. It is favored as a pre-contest or cutting steroid in bodybuilding and is valued in sports emphasizing speed and tendon strength due to its anabolic benefits without excess water or fat retention.
Conclusion:
Turinabol offers a balanced approach to anabolic steroid usage, providing muscle-building benefits with reduced risk of estrogenic and androgenic side effects. Consultation with a healthcare professional is essential before initiating Turinabol use to ensure safe and effective outcomes.